The Valley Desk

NCT01143402 · Interventional trial

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Overall registry status Completed

Phase 2

Conditions Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension, Recurrent Uveal Melanoma, Small Size Posterior Uveal Melanoma, Stage IV Uveal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov